Status:
NOT_YET_RECRUITING
Effectiveness of MD on MetS Patients
Lead Sponsor:
Assiut University
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The metabolic syndrome (MetS), is a complicated condition linked to coronary artery disease.This group includes visceral obesity (abdominal or android type obesity), insulin resistance (IR), hypertens...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- All people diagnosed as metabolic syndrome
- (Hypertension(systolic BP≥130 or Diastolic BP ≥85)
- prediabetes fasting plasma glucose(100-125),oral glucose tolerance test(140-199)Hba1c(5.7-6.4)ADA
- Diabetes, fasting\>125, oral glucose tolerance test\>200, Hba1c≥6.5 ADA .
- Hyperlipidaemia(TG≥150 mg\\dl-HDL\<40 in male and \<50 in female) \[12\]
- Obesity(waist circumference ≥102cm in male and ≥88cm in female) \[12\]
- Exclusion criteria:
- Type 1 diabetes
- Patients with renal or advanced liver disease(Failure)
- Oral contraceptives, psychiatric, neurologic medications and steroid therapy
- Patients with heart failure and presence of stent
- Endocrine disease (Thyroid disease especially hypothyroidism-Cushing disease)
Exclusion
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2027
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT06961682
Start Date
May 1 2025
End Date
March 30 2027
Last Update
May 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.